ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2025
Pain and lymphedema characteristics of women with breast cancer-related lymphedema with and without type 2 diabetes mellitus.
Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimThis study aimed to compare the pain and lymphedema characteristics of women with breast cancer-related lymphedema (BCRL) with and without type 2 diabetes mellitus (T2DM).
methodsA case-control study was conducted with 105 breast cancer survivors diagnosed with unilateral BCRL, divided into T2DM (n = 51) and non-T2DM (n = 54) groups. For pain characteristics, Visual Analog Scale (VAS) and Self-administered Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) were used. In addition, circumference measurement, the Lymphedema Life Impact Scale (LLIS), and Lymphedema Quality of Life Questionnaire (LYMQOL) were applied to determine the severity of lymphedema and its impact on quality of life. Statistical analysis was performed using t-tests, Mann-Whitney U tests, and Chi-square tests.
resultsT2DM patients exhibited significantly higher pain intensity (VAS) (p
conclusionT2DM significantly amplifies pain and worsens lymphedema-related outcomes in BCRL patients, underscoring the need for targeted, multidisciplinary interventions that address metabolic, physical, and psychosocial factors. Although lymphedema severity, duration, and volume were significantly higher in the T2DM group, these factors may have also contributed to the reduced functional status and quality of life outcomes independently of T2DM. Future research should explore the long-term relationship between T2DM, pain, and lymphedema to develop comprehensive care strategies for this population.
Indexed as
Identifiers
40627227What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.